Main Article Content
Abstract
RÉSUMÉ
La fibrillation atriale paroxystique sur faisceau-accessoire (pré-excitée), peut constituer la présentation inaugurale d’un syndrome de Wolff-Parkinson-White. C’est une affection souvent mal tolérée, pouvant rapidement engager le pronostic vital, et dont la prise en charge souffre de nombreuses limites dans notre contexte. La méconnaissance de ses spécificités diagnostique et thérapeutique peut conduire à la prescription de bloqueurs du nœud auriculo-ventriculaire, potentiellement responsables d’une dégénérescence en fibrillation ventriculaire.
ABSTRACT
Parosysmal atrial fibrillation with pre-excitation (accessory pathway), can be the earliest presentation of the wolf- parkinson-white syndrome. It is usually poorly tolerated by the patient, severe enough to impair vital prognosis. The management of this condition has several limitations in our setting. The unawareness of diagnostic and therapeutic particularities concerning this condition can lead to prescription of atrioventricular nodal blocking drugs in these patients which can result in ventricular fibrillation.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- - Bhatia A, Sra J, Akhtar M. Preexcitation syndromes. Curr Probl Cardiol 2016;41:99_137
- - Al-Khatib SM, Pritchett ELC. Clinical features of Wolff- Parkinson-White syndrome. Am Heart J 1999 ; 138 : 403-413
- - Obeyesekere MN, Leong-Sit P, Massel D, Manlucu J, Modi S, Krahn AD, et al. Risk of arrhythmia and sudden death in patients with asymptomaticpreexcitation: a meta-analysis. Circulation 2012;125:2308–15.
- - Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, PetrettaA, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation 2012;125:661–8.
- - Blomström-Lundqvist C, Scheinman MM, Aliot EM. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. J Am Coll Cardiol 2003;42:1493–531.
- - Blomström-Lundqvist C, Scheinman MM, Aliot EM. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. J Am Coll Cardiol 2003;42:1493–531.
- - Clément Tatar. Et dire que la vie ne tient qu’à un fil : caractéristiques cliniques et electrophysiologiques des patients présentant un syndrome de Wolff-Parkinson-White malin. Sciences du Vivant [q-bio].2009.{hal.01732740}
- - Etheridge SP, Escudero CA, Blaufox AD, Law IH, Dechert-Crooks BE, Stephenson EA, Dubin AM, Ceresnak SR, Motonaga KS, Skinner JR, Marcondes LD, Perry JC, Collins KK, Seslar SP, Cabrera M, Uzun O, Cannon BC, Aziz PF, Kubus P, Tanel RE, Valdes SO, Sami S, Kertesz NJ, Maldonado J, Erickson C, Moore JP, Asakai H, Mill L, Abcede M, Spector ZZ, Menon S, Shwayder M, Bradley DJ, Cohen MI, Sanatani S. Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. JACC Clin lectrophysiol 2018;4:433_444.
- - Morady F, DiCarlo LA Jr, Baerman JM, De Buitleir M. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 1987;10:492_496.
- - Sellers TD Jr, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome.Analysis during atrial fibrillation. Circulation 1977;56:260_267.
- - Boriani G, Biffi M, Frabetti L, Azzolini U, Sabbatani P, Bronzetti G, Capucci A, Magnani B. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996;131:1214_1216.
References
- Bhatia A, Sra J, Akhtar M. Preexcitation syndromes. Curr Probl Cardiol 2016;41:99_137
- Al-Khatib SM, Pritchett ELC. Clinical features of Wolff- Parkinson-White syndrome. Am Heart J 1999 ; 138 : 403-413
- Obeyesekere MN, Leong-Sit P, Massel D, Manlucu J, Modi S, Krahn AD, et al. Risk of arrhythmia and sudden death in patients with asymptomaticpreexcitation: a meta-analysis. Circulation 2012;125:2308–15.
- Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, PetrettaA, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation 2012;125:661–8.
- Blomström-Lundqvist C, Scheinman MM, Aliot EM. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. J Am Coll Cardiol 2003;42:1493–531.
- Blomström-Lundqvist C, Scheinman MM, Aliot EM. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. J Am Coll Cardiol 2003;42:1493–531.
- Clément Tatar. Et dire que la vie ne tient qu’à un fil : caractéristiques cliniques et electrophysiologiques des patients présentant un syndrome de Wolff-Parkinson-White malin. Sciences du Vivant [q-bio].2009.{hal.01732740}
- Etheridge SP, Escudero CA, Blaufox AD, Law IH, Dechert-Crooks BE, Stephenson EA, Dubin AM, Ceresnak SR, Motonaga KS, Skinner JR, Marcondes LD, Perry JC, Collins KK, Seslar SP, Cabrera M, Uzun O, Cannon BC, Aziz PF, Kubus P, Tanel RE, Valdes SO, Sami S, Kertesz NJ, Maldonado J, Erickson C, Moore JP, Asakai H, Mill L, Abcede M, Spector ZZ, Menon S, Shwayder M, Bradley DJ, Cohen MI, Sanatani S. Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. JACC Clin lectrophysiol 2018;4:433_444.
- Morady F, DiCarlo LA Jr, Baerman JM, De Buitleir M. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 1987;10:492_496.
- Sellers TD Jr, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome.Analysis during atrial fibrillation. Circulation 1977;56:260_267.
- Boriani G, Biffi M, Frabetti L, Azzolini U, Sabbatani P, Bronzetti G, Capucci A, Magnani B. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996;131:1214_1216.